Results
1 -
10 of
14
(Click
here to explore results)
Advances in Nucleic Acid Therapeutics, CHAPTER 6 Splicing Modulation for Therapeutics . Elena Daoutsali, Annemieke Aartsma-Rus
, 2019
, Pages 103-125
Advances in Nucleic Acid Therapeutics, CHAPTER 1 History and Development of Nucleotide Analogues in Nucleic Acids Drugs . Sudhir Agrawal, Michael J. Gait
, 2019
, Pages 1-21
Phenotypic Drug Discovery, Chapter 8 Identification of a Novel Class of Small Molecules for Spinal Muscular Atrophy Through High-throughput Phenotypic Screening . Susanne E. Swalley, Atwood K. Cheung
, 2021
, Pages 140-159
Advances in Nucleic Acid Therapeutics, CHAPTER 4 Antisense Technology: Liver Targeting and Beyond for Drug Discovery . Richard S. Geary, Brenda F. Baker, Brett P. Monia
, 2019
, Pages 62-79
Advances in Nucleic Acid Therapeutics, CHAPTER 10 Conjugate-mediated Delivery of RNAi-based Therapeutics: Enhancing Pharmacokinetics–Pharmacodynamics Relationships of Medicinal Oligonucleotides . Bruno M. D. C. Godinho, Andrew H. Coles, Anastasia Khvorova
, 2019
, Pages 206-232
Advances in Nucleic Acid Therapeutics, Foreword
, 2019
, Pages P007-P008
Advances in Nucleic Acid Therapeutics, CHAPTER 7 Targeting Toxic Repeats . M. Leontien van der Bent, Remco T. P. van Cruchten, Derick G. Wansink
, 2019
, Pages 126-150
Protein Degradation with New Chemical Modalities: Successful Strategies in Drug Discovery and Chemical Biology, Chapter 14 Classes, Modes of Action and Selection of New Modalities in Drug Discovery . Eric Valeur
, 2020
, Pages 277-316
Advances in Nucleic Acid Therapeutics, CHAPTER 3 The Medicinal Chemistry of RNase H-activating Antisense Oligonucleotides . Punit P. Seth, Eric E. Swayze
, 2019
, Pages 32-61
Advances in Nucleic Acid Therapeutics, CHAPTER 9 Oligonucleotide Targeting of Long Non-coding RNAs . I. Blokhin, O. Khorkova, J. Hsiao, C. Wahlestedt
, 2019
, Pages 181-205